...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Phase 1b/2 trial expected to initiate 1Q 2019
1
Mar 06, 2019 02:07PM

Mar 06, 2019 02:20PM

aaacccchhhh,,,,,Bear,,,surely we must have learned by now from past history that our team generally can't meet their guidelines or milestones for time or money!!!,,,,,we definitely shouldn't expect to be disappointed when time lines are given,,they are actually meaningless to Management. Which is a real issue to those on the sidelines watching our sister company.... jmo

2
Mar 06, 2019 04:59PM
1
Mar 06, 2019 07:05PM
1
Mar 07, 2019 07:38AM
6
Mar 07, 2019 09:36AM
1
Mar 07, 2019 11:17AM
1
Mar 07, 2019 01:27PM
Share
New Message
Please login to post a reply